Literature DB >> 9285043

Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene.

T Brüning1, M Lammert, M Kempkes, R Thier, K Golka, H M Bolt.   

Abstract

Suspected nephrocarcinogenic effects of trichloroethene (TRI) in humans are attributed to metabolites derived from the glutathione transferase (GST) pathway. The influence of polymorphisms of GSTM1 and GSTT1 isoenzymes on the risk of renal cell cancer in subjects having been exposed to high levels of TRI over many years was investigated. GSTM1 and GSTT1 genotypes were determined by internal standard controlled polymerase chain reaction. Fourty-five cases with histologically verified renal cell cancer and a history of long-term occupational exposure to high concentrations of TRI were studied. A reference group consisted of 48 workers from the same geographical region with similar histories of occupational exposures to TRI but not suffering from any cancer. Among the 45 renal cell cancer patients, 27 carried at least one functional GSTM1 gene (GSTT1 +) and 18 at least one functional GSTT1 gene (GSTT1 +). Among the 48 reference workers, 17 were GSTM1 + and 31 were GSTT1 +. Odds ratio for renal cell cancer were 2.7 for GSTM1 + individuals (95% CI, 1.18-6.33; P < 0.02) and 4.2 for GSTT1 + individuals (95% CI, 1.16-14.91; P < 0.05), respectively. The data support the present concept of the nephrocarcinogenicity of TRI.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285043     DOI: 10.1007/s002040050432

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  27 in total

Review 1.  The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine.

Authors:  Hermann M Bolt; Peter H Roos; Ricarda Thier
Journal:  Int Arch Occup Environ Health       Date:  2003-03-01       Impact factor: 3.015

2.  PharmGKB summary: very important pharmacogene information for GSTT1.

Authors:  Caroline F Thorn; Yuan Ji; Richard M Weinshilboum; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-08       Impact factor: 2.089

3.  Re-assessment of the influence of polymorphisms of phase-II metabolic enzymes on renal cell cancer risk of trichloroethylene-exposed workers.

Authors:  Bernd Wiesenhütter; Silvia Selinski; Klaus Golka; Thomas Brüning; Hermann M Bolt
Journal:  Int Arch Occup Environ Health       Date:  2007-05-04       Impact factor: 3.015

4.  Association of glutathione S-transferase M1, T1, and P1 polymorphisms with renal cell carcinoma: evidence from 11 studies.

Authors:  Cheng-You Jia; Yu-Jin Liu; Xian-Ling Cong; Yu-Shui Ma; Ran Sun; Da Fu; Zhong-Wei Lv
Journal:  Tumour Biol       Date:  2013-12-15

5.  Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: kidney effects.

Authors:  Hong Sik Yoo; Blair U Bradford; Oksana Kosyk; Takeki Uehara; Svitlana Shymonyak; Leonard B Collins; Wanda M Bodnar; Louise M Ball; Avram Gold; Ivan Rusyn
Journal:  J Toxicol Environ Health A       Date:  2015

6.  Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms.

Authors:  S Karami; P Boffetta; N Rothman; R J Hung; T Stewart; D Zaridze; M Navritalova; D Mates; V Janout; H Kollarova; V Bencko; N Szeszenia-Dabrowska; I Holcatova; A Mukeria; J Gromiec; S J Chanock; P Brennan; W-H Chow; L E Moore
Journal:  Carcinogenesis       Date:  2008-06-19       Impact factor: 4.944

7.  Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals.

Authors:  L Buzio; G De Palma; P Mozzoni; M Tondel; C Buzio; I Franchini; O Axelson; A Mutti
Journal:  Occup Environ Med       Date:  2003-10       Impact factor: 4.402

Review 8.  Glutathione S-transferases in kidney and urinary bladder tumors.

Authors:  Tatjana Simic; Ana Savic-Radojevic; Marija Pljesa-Ercegovac; Marija Matic; Jasmina Mimic-Oka
Journal:  Nat Rev Urol       Date:  2009-05       Impact factor: 14.432

Review 9.  [Perspectives for molecular diagnostics exemplified by urothelial bladder carcinoma].

Authors:  M-O Grimm; M Burchardt; W A Schulz
Journal:  Urologe A       Date:  2003-04-08       Impact factor: 0.639

10.  A framework and case studies for evaluation of enzyme ontogeny in children's health risk evaluation.

Authors:  Gary Ginsberg; Suryanarayana V Vulimiri; Yu-Sheng Lin; Jayaram Kancherla; Brenda Foos; Babasaheb Sonawane
Journal:  J Toxicol Environ Health A       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.